Gainers
- Asana, Inc. (NYSE:ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.
- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) shares rose 20.5% to $0.3485 in pre-market trading after gaining around 6% on Wednesday. AcelRx Pharmaceuticals, last month, posted a Q2 loss of $0.06 per share.
- Revance Therapeutics, Inc. (NASDAQ:RVNC) rose 18.4% to $24.66 in pre-market trading as the company reported the FDA approval of DAXXIFY for injection, a peptide-formulated neuromodulator with long-lasting results.
- Bright Green Corporation (NASDAQ:BGXX) rose 15.2% to $1.80 in pre-market trading as the company reported pricing of $10.0 million private placement.
- Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) shares rose 12% to $1.96 in pre-market trading after gaining over 4% on Wednesday.
- Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 11.8% to $0.9702 in pre-market trading after declining 11% on Wednesday. Rubius Therapeutics, last month, posted a Q2 loss of $0.49 per share.
- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) rose 11% to $0.1040 in pre-market trading.
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) rose 10.4% to $1.17 in pre-market trading. The company, last month, posted a wider Q2 loss.
- First High-School Education Group Co., Ltd. (NYSE:FHS) rose 9.2% to $0.70 in pre-market trading.
- ShiftPixy, Inc. (NASDAQ:PIXY) rose 8.8% to $12.20 in pre-market trading after declining over 4% on Wednesday.
- Heliogen, Inc. (NYSE:HLGN) rose 8.6% to $2.40 in pre-market tradinh.
- GameStop Corp. (NYSE:GME) rose 7.4% to $25.82 in pre-market trading after the company reported better-than-expected earnings for its second quarter and also announced a partnership with cryptocurrency exchange FTX to bring more customers to the digital asset space.
